Location History:
- Machida, JA (1977 - 1978)
- Machida, JP (1980 - 1992)
- Tokyo, JP (1993 - 2000)
Company Filing History:
18 out of 730 
6 out of 4,179 
2 out of 104 
Years Active: 1977-2000
Title: Moriyuki Sato: Innovator in Biotechnological Patents
Introduction
Moriyuki Sato, a remarkable inventor based in Tokyo, Japan, has made significant contributions to the field of biotechnology, particularly through his innovative patent work. With an impressive portfolio of 26 patents, Sato has consistently advanced the knowledge and applications of biologically active peptides and their derivatives.
Latest Patents
Sato's latest patents include a groundbreaking G-CSF conjugate, which features novel human granulocyte colony-stimulating factor (hG-CSF) polypeptide derivatives. These innovations involve the substitution of amino acids within the hG-CSF polypeptide sequence, along with methods for producing these derivatives using specialized microorganisms. Furthermore, Sato has developed a monoclonal antibody that specifically binds to hG-CSF polypeptide derivatives. Another notable patent outlines a DNA coding for a unique motilin analog peptide, featuring leucine in place of methionine at the 13th position, produced via gene recombination techniques.
Career Highlights
Throughout his career, Moriyuki Sato has collaborated with esteemed organizations, including Kyowa Hakko Kogyo Co., Ltd. and Abbott Laboratories Corporation. His innovative approach to biotechnological research has garnered attention and respect within the scientific community, leading to numerous patents that have the potential to revolutionize medical treatments.
Collaborations
Collaborating with fellow researchers such as Seiga Itoh and Kazuo Yamaguchi, Sato continues to push the boundaries of scientific discovery. Their combined expertise has enhanced the research output and effectiveness of the projects they have undertaken together, fostering an environment of innovation and creativity.
Conclusion
Moriyuki Sato stands as a prominent figure in the realm of biotechnological innovations, with a proven track record of inventiveness. His contributions through patent applications not only showcase his expertise but also indicate a promising future for advancements in health sciences driven by his work.